Reducing The Impact Of Chronic Kidney Disease (CKD): Opportunities For Randomized Clinical Trials
 - July 19–20, 2011 - Natcher Conference Center
Home Registration Logistics Agenda Hotel

REDUCING THE IMPACT OF CHRONIC KIDNEY DISEASE (CKD): OPPORTUNITIES FOR RANDOMIZED CLINICAL TRIALS

Meeting Goals:
  1. Discuss critical elements of the study design to optimize the conduct and impact of Phase III clinical trials in CKD.
  2. Identify interventions and therapies for CKD that are currently in clinical trials or are ready to be evaluated in clinical trials.
  3. Discuss mechanisms for pathways of cooperation among industry, academia, government, and patient advocacy groups for CKD trials.

For questions concerning program content, contact:
Dr. Michael Flessner, NIDDK, NIH
flessnermf@niddk.nih.gov

Dr. Yining Xie, NIDDK, NIH
xieyi@niddk.nih.gov


For registration information, contact:
Mary Compton
Conference Planner
The Scientific Consulting Group, Inc.
656 Quince Orchard Road, Suite 210
Gaithersburg, MD 20878-1409
Tel:  (301) 670-4990 x249
Fax:  (301) 670-3815
E-mail:  mcompton@scgcorp.com
NIH NIDDK DHHS